A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Inclusion Criteria
Exclusion Criteria
CABA, Buenos Aires 1114, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires C1123AAO, Argentina
CABA, 1405, Argentina
City of Buenos Aires, 1425, Argentina
Santiago de Chlie, Santiago Metropolitan 8207257, Chile
Shanghai Shi, Shanghai Sheng 200011, China
Bogota D.C, 110221, Colombia
Le Kremlin-Bictre, 94270, France
Toyoake-shi, Aichi-ken 470-1192, Japan
Kitakyushu-shi, Fukuoka 807-8556, Japan
Nishinomiya-shi, Hyōgo 6638501, Japan
Kahoku-gun, Ishikawa-ken 9200293, Japan
Kawasaki-shi, Kanagawa 2168511, Japan
Shimotsugagun, Tochigi 3210293, Japan
Bunkyo-ku, Tokyo 1138421, Japan
Bunkyo-ku, Tokyo 1138519, Japan
Chuo-ku, Tokyo 1048560, Japan
Meguro-ku, Tokyo 1528902, Japan
Meguro-ku, Tokyo 1538515, Japan
Shinagawa-ku, Tokyo 1420054, Japan
Seongdong-gu, Seoul 04763, South Korea